- Report
- February 2024
Slovenia
From €2720EUR$2,850USD£2,279GBP
- Report
- February 2024
Slovakia
From €2720EUR$2,850USD£2,279GBP
- Report
- February 2024
Singapore
From €2720EUR$2,850USD£2,279GBP
- Report
- February 2024
Cuba
From €2720EUR$2,850USD£2,279GBP
- Report
- February 2024
Croatia
From €2720EUR$2,850USD£2,279GBP
- Report
- February 2024
Costa Rica
From €2720EUR$2,850USD£2,279GBP
- Report
- February 2024
Global
From €26245EUR$27,500USD£21,990GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- July 2024
- 228 Pages
Global
From €2534EUR$2,655USD£2,123GBP

The Immunoassay Instrument market is a segment of the In Vitro Diagnostics (IVD) industry. Immunoassay instruments are used to detect and measure the presence of antigens or antibodies in a sample. These instruments are used in a variety of clinical settings, including hospitals, laboratories, and research facilities. Immunoassay instruments are used to diagnose diseases, monitor drug levels, and detect environmental contaminants.
Immunoassay instruments are typically automated, allowing for high-throughput testing. They are also highly sensitive and specific, making them ideal for clinical applications. Immunoassay instruments are available in a variety of formats, including benchtop, microplate, and point-of-care systems.
Some of the major companies in the Immunoassay Instrument market include Abbott, Roche, Siemens, Thermo Fisher Scientific, and Danaher. Show Less Read more